Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
fondaparinux coagulation factor x small molecule NA drugbank Hip Fractures[MeSHID:D006620]
Disease Management[MeSHID:D019468]
Malignant Neoplasms[MeSHID:D009369]
Thrombosis[MeSHID:D013927]
Cessation of life[MeSHID:D003643]
Deep Vein Thrombosis[MeSHID:D020246]
Operative Surgical Procedures[MeSHID:D013514]
Myocardium[MeSHID:D009206]
Knee[MeSHID:D007717]
Myocardial Infarction[MeSHID:D009203]		 NA approved,investigational inhibitor
fondaparinux antithrombin-iii small molecule NA drugbank , DGIDB Hip Fractures[MeSHID:D006620]
Disease Management[MeSHID:D019468]
Malignant Neoplasms[MeSHID:D009369]
Thrombosis[MeSHID:D013927]
Cessation of life[MeSHID:D003643]
Deep Vein Thrombosis[MeSHID:D020246]
Operative Surgical Procedures[MeSHID:D013514]
Myocardium[MeSHID:D009206]
Knee[MeSHID:D007717]
Myocardial Infarction[MeSHID:D009203]		 17.82 approved,investigational potentiator
fondaparinux antithrombin-iii small molecule NA drugbank , DGIDB Hip Fractures[MeSHID:D006620]
Disease Management[MeSHID:D019468]
Malignant Neoplasms[MeSHID:D009369]
Thrombosis[MeSHID:D013927]
Cessation of life[MeSHID:D003643]
Deep Vein Thrombosis[MeSHID:D020246]
Operative Surgical Procedures[MeSHID:D013514]
Myocardium[MeSHID:D009206]
Knee[MeSHID:D007717]
Myocardial Infarction[MeSHID:D009203]		 17.82 approved,investigational potentiator,activator
click here to return to the previous page